Raymond James Trust N.A. Royalty Pharma PLC Transaction History
Raymond James Trust N.A.
- $4.55 Billion
- Q3 2024
A detailed history of Raymond James Trust N.A. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Raymond James Trust N.A. holds 24,858 shares of RPRX stock, worth $626,670. This represents 0.02% of its overall portfolio holdings.
Number of Shares
24,858
Previous 11,922
108.51%
Holding current value
$626,670
Previous $314,000
123.89%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding RPRX
# of Institutions
414Shares Held
283MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.04 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$948 Million0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$580 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$406 Million0.35% of portfolio
-
Viking Global Investors LP12.1MShares$305 Million1.32% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...